Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Denarius Metals Announces Closing of Rights Offering
02 mars 2023 14h34 HE
|
Denarius Metals Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 02, 2023 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius Metals” or the...
Denarius Metals Announces Rights Offering
16 janv. 2023 07h00 HE
|
Denarius Metals Corp.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius Metals” or “the...
Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody
06 déc. 2022 07h30 HE
|
Summit Therapeutics Inc.
Menlo Park, California, US, and Grand Cayman, Cayman Islands, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced a...
Press release Biocartis Group NV: Biocartis launches a rights offering (with extra-legal preferential rights for existing shareholders) of a maximum of 33,476,932 offered shares, amounting to a maximum of EUR 25,107,699.00
16 nov. 2022 01h00 HE
|
Biocartis NV
ADVERTISEMENT PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 16 November 2022, 07:00 CET Biocartis launches a rights offering (with extra-legal preferential rights for existing...
Persbericht Biocartis Group NV: Biocartis lanceert een aandelenuitgifte met voorkeurrecht (met extralegale voorkeurrechten voor bestaande aandeelhouders) van maximaal 33.476.932 aangeboden aandelen,ten bedrage van maximaal EUR 25.107.699,00
16 nov. 2022 01h00 HE
|
Biocartis NV
ADVERTENTIE PERSBERICHT: VOORKENNIS / GEREGLEMENTEERDE INFORMATIE16 november 2022, 07:00 CET Biocartis lanceert een aandelenuitgifte met voorkeurrecht (met extralegale voorkeurrechten voor bestaande...
Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering
09 août 2022 13h37 HE
|
Summit Therapeutics Inc.
Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its fully-subscribed...
Summit Therapeutics Announces Commencement of $100 Million Rights Offering
18 juil. 2022 16h05 HE
|
Summit Therapeutics Inc.
Menlo Park, CA, July 18, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to $100 million of the...
Millicom (Tigo) completes its rights offering with issuance of new shares
30 juin 2022 11h20 HE
|
Millicom International Cellular S.A.
Millicom (Tigo) completes its rights offering with issuance of new sharesLuxembourg, June 30, 2022 – On June 17, 2022, Millicom International Cellular S.A. (NASDAQ: TIGO) (“Millicom”) announced the...
Millicom (TIGO)’s rights offering fully subscribed
17 juin 2022 00h20 HE
|
Millicom International Cellular S.A.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, HONG KONG OR SINGAPORE OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION...
Millicom announces the terms of its rights offering
18 mai 2022 02h00 HE
|
Millicom International Cellular S.A.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, HONG KONG OR SINGAPORE OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION...